» Articles » PMID: 38887672

Navigating the Challenges of Clinical Trial Professionals in the Healthcare Sector

Overview
Specialty General Medicine
Date 2024 Jun 18
PMID 38887672
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical trials (CTs) are essential for medical advancements but face significant challenges, particularly in professional training and role clarity. Principal investigators, clinical research coordinators (CRCs), nurses, clinical trial pharmacists, and monitors are key players. Each faces unique challenges, such as maintaining protocol compliance, managing investigational products, and ensuring data integrity. Clinical trials' complexity and evolving nature demand specialized and ongoing training for these professionals. Addressing these challenges requires clear role delineation, continuous professional development, and supportive workplace environments to improve retention and trial outcomes. Enhanced training programs and a collaborative approach are essential for the successful conduct of clinical trials and the advancement of medical research.

References
1.
Baker J, Leek A, Salas H, Drotar D, Noll R, Rheingold S . Suggestions from adolescents, young adults, and parents for improving informed consent in phase 1 pediatric oncology trials. Cancer. 2013; 119(23):4154-61. DOI: 10.1002/cncr.28335. View

2.
Hornung C, Kerr J, Gluck W, Thomas Jones C . The Competency of Clinical Research Coordinators: The Importance of Education and Experience. Ther Innov Regul Sci. 2021; 55(6):1231-1238. DOI: 10.1007/s43441-021-00320-w. View

3.
Feehan A, Garcia-Diaz J . Investigator Responsibilities in Clinical Research. Ochsner J. 2020; 20(1):44-49. PMC: 7122254. DOI: 10.31486/toj.19.0085. View

4.
Beever D, Swaby L . An evaluation of risk-based monitoring in pragmatic trials in UK Clinical Trials Units. Trials. 2019; 20(1):556. PMC: 6734501. DOI: 10.1186/s13063-019-3619-6. View

5.
Andersen J, von Sehested C, Byrjalsen I, Popik S, Follin A, Bihlet A . Impact of monitoring approaches on data quality in clinical trials. Br J Clin Pharmacol. 2022; 89(6):1756-1766. DOI: 10.1111/bcp.15615. View